MediPal Holdings Corporation (TYO:7459)
Japan · Delayed Price · Currency is JPY 2,569.50
+1.50 (0.06%)
Oct 24, 2025, 3:30 PM JST
MediPal Holdings Revenue
MediPal Holdings had revenue of 945.16B JPY in the quarter ending June 30, 2025, with 3.94% growth. This brings the company's revenue in the last twelve months to 3.71T, up 3.51% year-over-year. In the fiscal year ending March 31, 2025, MediPal Holdings had annual revenue of 3.67T with 3.16% growth.
Revenue (ttm)
3.71T
Revenue Growth
+3.51%
P/S Ratio
0.14
Revenue / Employee
283.84M
Employees
13,061
Market Cap
527.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.67T | 112.60B | 3.16% |
| Mar 31, 2024 | 3.56T | 198.72B | 5.91% |
| Mar 31, 2023 | 3.36T | 69.09B | 2.10% |
| Mar 31, 2022 | 3.29T | 79.80B | 2.48% |
| Mar 31, 2021 | 3.21T | -41.95B | -1.29% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |